Katherine J. Wu's profile photo

Katherine J. Wu

Staff Writer at The Atlantic

Senior Producer at The Story Collider

Senior Editor at The Open Notebook

staff writer @TheAtlantic, covering science. also senior producer @storycollider, senior editor @Open_Notebook. (she/her)

Featured in: Favicon theatlantic.com Favicon theopennotebook.com Favicon medium.com Favicon msn.com Favicon globo.com Favicon nytimes.com Favicon indiatimes.com (+2) Favicon terra.com.br Favicon independent.co.uk Favicon clarin.com

Articles

  • 1 week ago | theatlantic.com | Katherine J. Wu

    Matthew J. Memoli has had an exceptionally good year. At the beginning of January, Memoli was a relatively little-known flu researcher running a small lab at the National Institute for Allergy and Infectious Diseases (NIAID) at the National Institutes of Health.

  • 2 weeks ago | theatlantic.com | Katherine J. Wu

    One of the most notable things about Robert F. Kennedy Jr.—the secretary of the Department of Health and Human Services, a federal agency tasked with “improving the health, safety, and well-being of America”—is how confidently he distorts the basics of health, safety, and well-being.

  • 1 month ago | theatlantic.com | Katherine J. Wu

    If the United States learned any lesson from HIV, it should have been that negligence can be a death sentence. In the early 1980s, the virus’s ravages were treated as “something that happens over there, only to those people,” Juan Michael Porter II, a health journalist and an HIV activist, told me. But the more the virus and the people it most affected were ignored, the worse the epidemic got.

  • 1 month ago | theatlantic.com | Katherine J. Wu

    By design, clinical trials ask their participants to take on risk. To develop new vaccines, drugs, or therapies, scientists first have to ask volunteers to try out those interventions, with no guarantee that they’ll work or be free of side effects. To minimize harm, researchers promise to care for and monitor participants through a trial’s end, long enough to collect the data necessary to determine if a therapy is effective and at what cost.

  • 1 month ago | theatlantic.com | Katherine J. Wu

    For most of the past century, the United States’ track record on infectious disease has been quite good. Thanks to major investments in public health, diseases such as smallpox, polio, yellow fever, malaria, measles, rubella, mumps, diphtheria, and tuberculosis have either been obliterated or become vanishingly rare. America “led the charge,” Aniruddha Hazra, an infectious-disease physician at UChicago Medicine, told me.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
42K
Tweets
7K
DMs Open
Yes
Katherine J. Wu, Ph.D.
Katherine J. Wu, Ph.D. @KatherineJWu
20 Sep 23

I suppose I am here now https://t.co/g1Q7dCV0vQ

Katherine J. Wu, Ph.D.
Katherine J. Wu, Ph.D. @KatherineJWu
29 Mar 23

these tricky mfers https://t.co/vm7AtB2SL0

Katherine J. Wu, Ph.D.
Katherine J. Wu, Ph.D. @KatherineJWu
25 Mar 23

RT @amymaxmen: My 2c on the latest in Covid origins @PostOpinions Genetic sequences from the Wuhan market can reveal so much, curbing bas…